Clinical Trial Update: Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 results indicate reduced toxicity from cord blood transplantation in patients with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED